(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 17.43% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.29%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Treace Medical Concepts's revenue in 2024 is $187,118,000.On average, 4 Wall Street analysts forecast TMCI's revenue for 2024 to be $13,761,269,714, with the lowest TMCI revenue forecast at $13,740,519,985, and the highest TMCI revenue forecast at $13,810,118,035. On average, 4 Wall Street analysts forecast TMCI's revenue for 2025 to be $16,252,534,059, with the lowest TMCI revenue forecast at $16,037,811,416, and the highest TMCI revenue forecast at $16,465,095,271.
In 2026, TMCI is forecast to generate $18,701,496,129 in revenue, with the lowest revenue forecast at $18,112,784,322 and the highest revenue forecast at $19,792,524,293.